ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 75 filers reported holding ALLAKOS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $97,023 | -93.8% | 22,253 | -93.7% | 0.00% | -100.0% |
| Q1 2023 | $1,571,495 | -51.5% | 353,145 | -8.3% | 0.01% | -55.6% |
| Q4 2022 | $3,241,498 | +74.6% | 384,976 | -35.1% | 0.02% | +80.0% |
| Q2 2022 | $1,856,000 | -55.0% | 593,044 | -18.0% | 0.01% | -56.5% |
| Q1 2022 | $4,121,000 | -38.0% | 722,911 | +6.5% | 0.02% | -36.1% |
| Q4 2021 | $6,648,000 | +56.0% | 679,031 | +1587.0% | 0.04% | +33.3% |
| Q3 2021 | $4,261,000 | -44.3% | 40,251 | -55.1% | 0.03% | -49.1% |
| Q2 2021 | $7,653,000 | -27.3% | 89,644 | -2.3% | 0.05% | -31.2% |
| Q1 2021 | $10,528,000 | +200.5% | 91,727 | +266.5% | 0.08% | +165.5% |
| Q4 2020 | $3,504,000 | +219.4% | 25,030 | +1.5% | 0.03% | -9.4% |
| Q1 2020 | $1,097,000 | +237.5% | 24,654 | +624.3% | 0.03% | +433.3% |
| Q4 2019 | $325,000 | -89.6% | 3,404 | -91.4% | 0.01% | -88.9% |
| Q3 2019 | $3,118,000 | +425.8% | 39,654 | +170.7% | 0.05% | +200.0% |
| Q1 2019 | $593,000 | – | 14,647 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |